Medline (MDLN) EBITDA (2025 - 2026)

Medline (MDLN) reported EBITDA of $120.0 million for Q1 2026, down 62.26% year-over-year from $318.0 million in Q1 2025, and down 62.26% on a QoQ basis from $318.0 million in Q1 2025.

Medline (MDLN) has 2 years of EBITDA data on file, last reported at $120.0 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Intuitive Surgical 146.28 Bn 141.88 Bn 1.83 Bn 799.70 Mn
2 Becton Dickinson 41.14 Bn 40.13 Bn 2.15 Bn 93.00 Mn
3 Medline 29.16 Bn 35.00 Bn 1.84 Bn 120.00 Mn
4 Resmed 27.13 Bn 25.47 Bn 890.98 Mn 499.81 Mn
5 West Pharmaceutical Services 22.71 Bn 22.19 Bn 296.40 Mn 177.10 Mn
6 Solventum 13.26 Bn 13.26 Bn 1.10 Bn 81.00 Mn
7 Align Technology 12.22 Bn 11.16 Bn 736.59 Mn 141.96 Mn
8 Cooper Companies 11.79 Bn 11.66 Bn 695.20 Mn 203.30 Mn
9 Baxter International 9.47 Bn 7.42 Bn 891.00 Mn 66.00 Mn
10 Aptargroup 7.19 Bn 6.99 Bn 351.91 Mn 171.81 Mn

Historic Data

Download Data 🔒
DateValue
Mar 28, 2026 120.00 Mn
Mar 29, 2025 318.00 Mn